AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17327251 — intervention group
Group type: EXPERIMENTAL
Intervention: Light anaesthesia
Number of subjects: 40
Study 17327251 — intervention group
Group type: COMPARATOR
Intervention: Five different conditions of anaesthesia (intubation, skin incision, deep anaesthesia, moderate anaesthesia, light anaesthesia)
Number of subjects: 40
Study 17327251 — intervention group
Group type: EXPERIMENTAL
Intervention: Second test point
Number of subjects: 40
Study 15076648 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban dust exposure at 500 microg/m3 for 3 hours
Number of subjects: 30
Study 15076648 — intervention group
Group type: COMPARATOR
Intervention: Control air exposure
Number of subjects: 30
Study 11425688 — intervention group
Group type: EXPERIMENTAL
Intervention: High oxygen-transmissible soft lenses
Number of subjects: 246
Study 11425688 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyper oxygen-transmissible soft lenses
Number of subjects: 246
Study 11425688 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyper oxygen-transmissible RGP lenses
Number of subjects: 246
Study 11425688 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid gas-permeable lenses
Number of subjects: 246
Study 11425688 — intervention group
Group type: EXPERIMENTAL
Intervention: All test lenses
Number of subjects: 246
Study 11425688 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 246
Study 9532327 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem (1 g every 8 hours for 3-14 days, average 9 days)
Number of subjects: 95
Study 9532327 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (1 g every 8 hours) and Amikacin (0.5 g every 12 hours for 2-14 days, average 9 days)
Number of subjects: 95
Study 7526728 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anaesthetic technique
Number of subjects: 72
Study 7526728 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 72
Study 2644339 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study 2644339 — intervention group
Group type: COMPARATOR
Intervention: Imipramine (control)
Number of subjects: 0
Study 339322 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 6
Study 339322 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin and somatostatin
Number of subjects: 6
Study 339322 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin
Number of subjects: 6
Study 339322 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6
Study 31707500 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily symptom screening using the SPARK platform
Number of subjects: 30
Study 31707500 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 30
Study 31023034 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG gating during computed tomography (CT) acquisition
Number of subjects: 62
Study 31023034 — intervention group
Group type: COMPARATOR
Intervention: Non-ECG gating during computed tomography (CT) acquisition
Number of subjects: 62
Study 28954640 — intervention group
Group type: EXPERIMENTAL
Intervention: β2‐1 fructan (3×5 g/d)
Number of subjects: 30
Study 28954640 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (3×5 g/d)
Number of subjects: 30
Study 28954640 — intervention group
Group type: EXPERIMENTAL
Intervention: β2‐1 fructan
Number of subjects: 30
Study 25517389 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous exercise
Number of subjects: 20
Study 25517389 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval exercise
Number of subjects: 20
Study 25517389 — intervention group
Group type: COMPARATOR
Intervention: Control ABPM (no exercise)
Number of subjects: 20
Study 23804157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement directed kyphoplasty system (CDKS)
Number of subjects: 77
Study 23804157 — intervention group
Group type: COMPARATOR
Intervention: Vertebroplasty
Number of subjects: 77
Study 23804157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement directed kyphoplasty system (CDKS) and Vertebroplasty
Number of subjects: 77
Study 20945252 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention intervention to increase fruit and vegetable intake by two extra portions daily over 7 days
Number of subjects: 0
Study 20945252 — intervention group
Group type: COMPARATOR
Intervention: Control condition performing an equivalent neutral task
Number of subjects: 0
Study 19738372 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin treatment
Number of subjects: 23247
Study 19738372 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind design
Number of subjects: 23247
Study 19738372 — intervention group
Group type: EXPERIMENTAL
Intervention: Short maximum allowed delay from symptom onset to randomization
Number of subjects: 23247
Study 19738372 — intervention group
Group type: EXPERIMENTAL
Intervention: Time effect
Number of subjects: 23247
Study 17083637 — intervention group
Group type: EXPERIMENTAL
Intervention: SLIPA (Streamlined Liner of the Pharynx Airway)
Number of subjects: 36
Study 17083637 — intervention group
Group type: COMPARATOR
Intervention: SS-LM (Soft Seal Laryngeal Mask)
Number of subjects: 36
Study 14697435 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate
Number of subjects: 30
Study 14697435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11386392 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy plus imagery (10-minute guided imagery sessions after each therapy session, plus home practice twice weekly)
Number of subjects: 13
Study 11386392 — intervention group
Group type: COMPARATOR
Intervention: Therapy only (control group)
Number of subjects: 13
Study 9404369 — intervention group
Group type: EXPERIMENTAL
Intervention: R-salbutamol 1.25 mg
Number of subjects: 12
Study 9404369 — intervention group
Group type: EXPERIMENTAL
Intervention: Racemic salbutamol 2.5 mg
Number of subjects: 12
Study 9404369 — intervention group
Group type: EXPERIMENTAL
Intervention: S-salbutamol 1.25 mg
Number of subjects: 12
Study 9404369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8489327 — intervention group
Group type: EXPERIMENTAL
Intervention: Liothyronine
Number of subjects: 50
Study 8489327 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 50
Study 8489327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 3687684 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine exercise
Number of subjects: 63
Study 3687684 — intervention group
Group type: COMPARATOR
Intervention: Upright exercise
Number of subjects: 63
Study 29424676 — intervention group
Group type: EXPERIMENTAL
Intervention: Condoliase 1.25 U
Number of subjects: 194
Study 29424676 — intervention group
Group type: EXPERIMENTAL
Intervention: Condoliase 2.5 U
Number of subjects: 194
Study 29424676 — intervention group
Group type: EXPERIMENTAL
Intervention: Condoliase 5 U
Number of subjects: 194
Study 29424676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 29424676 — intervention group
Group type: EXPERIMENTAL
Intervention: All condoliase groups
Number of subjects: 194
Study 29424676 — intervention group
Group type: EXPERIMENTAL
Intervention: Condoliase groups
Number of subjects: 194
Study 27302721 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST) provided by a bilingual social worker
Number of subjects: 387
Study 27302721 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression remission (measured with Patient Health Questionnaire-9 and Hopkins Symptom Checklist-20)
Number of subjects: 387
Study 24843974 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Changqiang (GV 1) and Chengshan (BL 57) 30 min before surgery
Number of subjects: 120
Study 24843974 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture (shallow needling without electrical stimulation at a sham acupoint) 30 min before surgery
Number of subjects: 120
Study 24843974 — intervention group
Group type: COMPARATOR
Intervention: Blank group (no treatment before surgery)
Number of subjects: 120
Study 24843974 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture group
Number of subjects: 120
Study 24843974 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture group
Number of subjects: 120
Study 24843974 — intervention group
Group type: COMPARATOR
Intervention: Blank group
Number of subjects: 120
Study 22592900 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 2203
Study 22592900 — intervention group
Group type: COMPARATOR
Intervention: Ineffective revascularization
Number of subjects: 2203
Study 20543219 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted-jump-rope training (n = 9)
Number of subjects: 24
Study 20543219 — intervention group
Group type: EXPERIMENTAL
Intervention: Unweighted-jump-rope training (n = 8)
Number of subjects: 24
Study 20543219 — intervention group
Group type: COMPARATOR
Intervention: No specific training program (n = 7)
Number of subjects: 24
Study 19014834 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg + Simvastatin 40 mg
Number of subjects: 872
Study 19014834 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 160 mg + Simvastatin 20 mg
Number of subjects: 872
Study 19014834 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 320 mg + Simvastatin 40 mg
Number of subjects: 872
Study 19014834 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 320 mg + Simvastatin 20 mg
Number of subjects: 872
Study 19014834 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 160/320 mg + Simvastatin 20 mg
Number of subjects: 872
Study 19014834 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 160/320 mg + Simvastatin 40 mg
Number of subjects: 872
Study 16898379 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative therapy failure criteria
Number of subjects: 876
Study 16898379 — intervention group
Group type: COMPARATOR
Intervention: WHO therapy failure criteria
Number of subjects: 876
Study 12814907 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle acupuncture
Number of subjects: 48
Study 12814907 — intervention group
Group type: COMPARATOR
Intervention: Sham laser stimulation
Number of subjects: 48
Study 12814907 — intervention group
Group type: COMPARATOR
Intervention: Laser acupuncture
Number of subjects: 48
Study 11185634 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral telmisartan 20 mg
Number of subjects: 24
Study 11185634 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral telmisartan 120 mg
Number of subjects: 24
Study 11185634 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous telmisartan 120 mg
Number of subjects: 24
Study 11185634 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral and i.v. telmisartan
Number of subjects: 24
Study 11185634 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral telmisartan
Number of subjects: 24
Study 8858631 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival mitomycin-C (MMC) administration (0.27 mg/ml for 5 minutes)
Number of subjects: 23
Study 8858631 — intervention group
Group type: COMPARATOR
Intervention: Intrascleral mitomycin-C (MMC) administration (0.27 mg/ml for 5 minutes)
Number of subjects: 23
Study 1298601 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium yeast 200 g Se1Tab/day
Number of subjects: 4065
Study 1298601 — intervention group
Group type: COMPARATOR
Intervention: Common yeast 1 Tab/day
Number of subjects: 4065
Study 6387672 — intervention group
Group type: EXPERIMENTAL
Intervention: Cornstarch powder
Number of subjects: 0
Study 6387672 — intervention group
Group type: EXPERIMENTAL
Intervention: Talcum powder
Number of subjects: 0
Study 6387672 — intervention group
Group type: COMPARATOR
Intervention: Control (no powder)
Number of subjects: 0
Study 29466081 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape
Number of subjects: 141
Study 29466081 — intervention group
Group type: COMPARATOR
Intervention: Sham tape
Number of subjects: 141
Study 29466081 — intervention group
Group type: COMPARATOR
Intervention: No tape
Number of subjects: 141
Study 29608685 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir/lamivudine
Number of subjects: 91
Study 29608685 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir monotherapy
Number of subjects: 91
Study 29608685 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (control arm)
Number of subjects: 91
Study 26869191 — intervention group
Group type: EXPERIMENTAL
Intervention: Omarigliptin (50 mg, once weekly for 4 weeks)
Number of subjects: 32
Study 26869191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 25041101 — intervention group
Group type: EXPERIMENTAL
Intervention: Farman entrainer and pediatric t-piece
Number of subjects: 60
Study 25041101 — intervention group
Group type: COMPARATOR
Intervention: Pediatric drawover apparatus
Number of subjects: 60
Study 22273781 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bundle ACL reconstruction
Number of subjects: 42
Study 22273781 — intervention group
Group type: COMPARATOR
Intervention: Single-bundle ACL reconstruction
Number of subjects: 42
Study 22273781 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SB and DB)
Number of subjects: 42
Study 19962297 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet supplemented with nuts
Number of subjects: 50
Study 19962297 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet supplemented with virgin olive oil
Number of subjects: 50
Study 19962297 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 50
Study 18607246 — intervention group
Group type: EXPERIMENTAL
Intervention: Active smoking
Number of subjects: 140
Study 18607246 — intervention group
Group type: COMPARATOR
Intervention: Nonactive smoking
Number of subjects: 140
Study 15809885 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone 75 mg/kg daily for 12 months
Number of subjects: 15
Study 12034649 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea patients
Number of subjects: 22
Study 12034649 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 22
Study 12034649 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea severity
Number of subjects: 22
Study 10463519 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 8 mg
Number of subjects: 2574
Study 10463519 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 16 mg
Number of subjects: 2574
Study 10463519 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2574
Study 7836086 — intervention group
Group type: EXPERIMENTAL
Intervention: S + RT (surgery plus radiotherapy)
Number of subjects: 80
Study 7836086 — intervention group
Group type: COMPARATOR
Intervention: S (surgery) alone
Number of subjects: 80
Study 7836086 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 80
Study 2239759 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) diet for 6 days
Number of subjects: 0
Study 2239759 — intervention group
Group type: COMPARATOR
Intervention: Long-chain triglycerides (LCT) diet for 6 days
Number of subjects: 0
Study 2239759 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) diet
Number of subjects: 0
Study 329741 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide as a single agent
Number of subjects: 100
Study 329741 — intervention group
Group type: EXPERIMENTAL
Intervention: Actinomycin D‐‐vincristine combination
Number of subjects: 100
Study 329741 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide‐‐methotrexate‐‐vincristine combination
Number of subjects: 100
Study 30282520 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy (FS) screening
Number of subjects: 44041
Study 28768788 — intervention group
Group type: EXPERIMENTAL
Intervention: Plate fixation
Number of subjects: 123
Study 28768788 — intervention group
Group type: COMPARATOR
Intervention: Elastic stable intramedullary nailing (ESIN)
Number of subjects: 123
Study 24943362 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT group
Number of subjects: 158
Study 24943362 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group
Number of subjects: 158
Study 24943362 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 158
Study 23731234 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankaferd Blood Stopper (ABS)
Number of subjects: 90
Study 23731234 — intervention group
Group type: COMPARATOR
Intervention: Control (regular tubeless PCNL)
Number of subjects: 90
Study 21570345 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 380
Study 18988277 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive glass S53P4 (BG)
Number of subjects: 25
Study 18988277 — intervention group
Group type: COMPARATOR
Intervention: Autogenous bone (AB)
Number of subjects: 25
Study 16566622 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (209 mg/day, SD: 91.7, range: 75-325 mg/day)
Number of subjects: 27
Study 16566622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 15038944 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 432
Study 15038944 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 432
Study 15038944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 432
Study 11159266 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral auricular acupuncture at the 'relaxation' point
Number of subjects: 55
Study 11159266 — intervention group
Group type: COMPARATOR
Intervention: Bilateral auricular acupuncture at the 'shenmen' point
Number of subjects: 55
Study 11159266 — intervention group
Group type: COMPARATOR
Intervention: Bilateral auricular acupuncture at a 'sham' point
Number of subjects: 55
Study 9777685 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemotherapy as an adjuvant treatment after curative resection of gastric cancer
Number of subjects: 0
Study 9777685 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 7792331 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical criteria
Number of subjects: 88
Study 7792331 — intervention group
Group type: COMPARATOR
Intervention: Research criteria
Number of subjects: 88
Study 3344781 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior chamber lenses with intracapsular fixation
Number of subjects: 37
Study 3344781 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior chamber lenses with posterior capsule left intact
Number of subjects: 37
Study 3344781 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior chamber lenses with ruptured posterior capsule
Number of subjects: 37
Study 30981943 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver assisted home-based cognitive remediation
Number of subjects: 0
Study 30981943 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based cognitive remediation
Number of subjects: 0
Study 28197749 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle-based training (two weekly group sessions lasting 60-90 minutes)
Number of subjects: 126
Study 26164666 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-L PEG plus bisacodyl
Number of subjects: 211
Study 26164666 — intervention group
Group type: COMPARATOR
Intervention: 4-L PEG
Number of subjects: 211
Study 23590671 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferasirox therapy
Number of subjects: 16
Study 23590671 — intervention group
Group type: COMPARATOR
Intervention: Control (no deferasirox therapy)
Number of subjects: 16
Study 21943026 — intervention group
Group type: EXPERIMENTAL
Intervention: In-country testing using two HIV rapid tests
Number of subjects: 2247
Study 21943026 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV prevalence by location
Number of subjects: 2247
Study 19044228 — intervention group
Group type: EXPERIMENTAL
Intervention: SCHWIND ESIRIS laser
Number of subjects: 22
Study 19044228 — intervention group
Group type: COMPARATOR
Intervention: WaveLight ALLEGRETTO WAVE Eye‐Q laser
Number of subjects: 22
Study 16945637 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct vision urethrotomy alone
Number of subjects: 72
Study 16945637 — intervention group
Group type: COMPARATOR
Intervention: Direct vision urethrotomy plus clean intermittent catheterization for 3 months
Number of subjects: 72
Study 16945637 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct vision urethrotomy following tubularized graft urethroplasty
Number of subjects: 72
Study 16945637 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct vision urethrotomy following tubularized island flap urethroplasty
Number of subjects: 72
Study 16945637 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct vision urethrotomy following onlay flap urethroplasty
Number of subjects: 72
Study 16945637 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct vision urethrotomy following urethral plate urethroplasty
Number of subjects: 72
Study 12417966 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg modafinil
Number of subjects: 60
Study 12417966 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg modafinil
Number of subjects: 60
Study 12417966 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 10868020 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of Triamcinolonhexacetonide
Number of subjects: 0
Study 10868020 — intervention group
Group type: COMPARATOR
Intervention: NSAID plus physiotherapy
Number of subjects: 0
Study 9160484 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed effects Poisson regression model for recurrent event data
Number of subjects: 0
Study 8438948 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm of ampicillin intravenously
Number of subjects: 22
Study 8438948 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm of ampicillin plus 0.5 gm of sulbactam intravenously
Number of subjects: 22
Study 3530031 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple instructions for the use of spacer aerosols
Number of subjects: 22
Study 3530031 — intervention group
Group type: EXPERIMENTAL
Intervention: Complicated manufacturer's instructions
Number of subjects: 22
Study 3530031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 30440834 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 10
Study 30440834 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 10